Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1439 of 5804
-
New combo therapy aims to fight rare nasal cancer before surgery
Disease control TerminatedSinonasal mucosal malignant melanoma (SNMM) is a nasal and paranasal sinus malignancy with a low incidence and extremely poor prognosis, exhibiting specificity in Asian populations. For resectable SNMM, the efficacy of neoadjuvant immunotherapy is unclear. This prospective clinic…
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New hope for tough psoriasis spots: tildrakizumab under the microscope
Disease control OngoingPsoriasis is a chronic inflammatory disease that affects between 2% and 4% of the French population.Some specific localizations are more difficult to manage, such as the scalp, nails, genital region and palmoplantar localizations. Tildrakizumab, an anti-interleukin-23 (IL-23) mo…
Sponsor: Clin4all • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Real-world study explores new drug for breast cancer
Disease control Recruiting nowTo evaluate the efficacy and safety of Disitamab vedotin (RC48-ADC) in patients with breast cancer.
Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:08 UTC
-
New pill combo aims to keep advanced breast cancer in check
Disease control Recruiting nowTo compare the efficacy and safety of capecitabine and cyclophosphamide (XC) versus physician's choice as maintenance therapy for patients with advanced breast cancer who achieved disease control after salvage treatment.
Phase: NA • Sponsor: Wenjin Yin • Aim: Disease control
Last updated Jun 26, 2026 16:12 UTC
-
Could a common antibiotic help calm dangerous IPF Flare-Ups?
Disease control Recruiting nowThis randomized controlled trial evaluates the therapeutic role of azithromycin in acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF). Baseline severity classification and stratification were performed using the SCALE-IPF framework (Severity Classification and Lung Eva…
Phase: NA • Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New mHealth program aims to lower depression and stress in black pregnant women
Knowledge-focused OngoingPerinatal Mood and Anxiety Disorders (PMADs) encompass a range of mental health disorders that occur during pregnancy and up to one year postpartum. Approximately 13% of women experience PMADs. This rate doubles for those with adverse perinatal outcomes (APO) and triples in Black…
Phase: PHASE2, PHASE3 • Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New pulse therapy for depression put to the test
Symptom relief CompletedTranscranial pulse stimulation (TPS) is a newly developed brain stimulation therapy from Austria \& Germany with highly promising applicability in neuropsychiatric disorders. Major depressive disorder (MDD) is the world's leading cause of disability. Novel treatment approaches ar…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Can a Low-Dose drug delay menopause? new trial aims to find out
Disease control OngoingThe investigators are proposing a prospective, randomized, double-blind, placebo-controlled pilot study assessing the ability of low-dose rapamycin to delay ovarian aging in women. Animal studies have shown the potential of rapamycin in slowing or reversing some age-associated pa…
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
School exercise program aims to solve sleep struggles in autistic kids
Symptom relief CompletedSleep problems are very common in children on the autism spectrum and can worsen daytime behaviour, learning, and family stress. Many families have limited access to specialist sleep services. This study evaluates a school-based, sensory-friendly physical activity program designe…
Phase: NA • Sponsor: Xili Wen • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Can pressurized oxygen clear long COVID brain fog?
Symptom relief Recruiting nowPost-COVID-19 syndrome is an assembly of symptoms, following an infection with Coronavirus disease 2019 (COVID-19). The syndrome is characterized by cognitive impairment, fatigue, sleep disorders, smell and taste disorders, pain and more. This long-term sequela can last for month…
Phase: NA • Sponsor: Assaf-Harofeh Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Can the HPV vaccine protect transplant patients? new study investigates
⭐️ VACCINE ⭐️ OngoingTo measure levels of HPV antibodies in post-solid-organ transplant recipients who have gotten the HPV9 vaccine.
Phase: PHASE4 • Sponsor: Medical College of Wisconsin • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:28 UTC
-
FRESH trial: healthier restaurant menus could cut cancer risk in minority communities
Prevention Recruiting nowWorking with independently owned restaurants, a common source of calorie-rich, nutrient-poor foods in predominantly minority, low-income urban neighborhoods, has the potential to improve dietary quality, and contribute to cancer prevention. This study uses systems science approac…
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Prevention
Last updated Jun 27, 2026 12:38 UTC
-
Shorter PTSD therapy may be just as effective for veterans
Symptom relief OngoingTrauma-related guilt is common and impairing among trauma survivors, particularly among Veterans with posttraumatic stress disorder (PTSD). The investigators' work shows that a brief treatment targeting trauma-related guilt, Trauma Informed Guilt Reduction Therapy (TrIGR), can re…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
MRNA vaccine takes on glioblastoma in first human trial
Disease control CompletedThis study is an open-label, first-in-human, dose-escalation study of CV09050101 mRNA vaccine (CVGBM) in patients with newly diagnosed "MGMT-unmethylated" Glioblastoma (GBM). Patients with isocitrate dehydrogenase (IDH)-wildtype astrocytoma with a molecular signature of "unmethyl…
Phase: PHASE1 • Sponsor: CureVac • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Mind over mood: brain training shows promise for depression
Symptom relief Recruiting nowThe goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as a stand-alone intervention for major depressive disorder
Phase: NA • Sponsor: Kymberly Young • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Spinal magnetic stimulation plus treadmill training shows promise for Parkinson's gait
Symptom relief CompletedGait changes appear and become the main cause of disability, loss of independence, falls, fractures and reduced quality of life for patients with Parkinson Disease. Optimal gait management is complex and challenging. Some characteristics, such as gait variability, postural instab…
Phase: NA • Sponsor: University of Sao Paulo General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New cancer diagnostic tool could change how doctors choose treatments
Diagnosis Recruiting nowThis is a multicenter, experimental preclinical study conducted on primary samples from patients diagnosed with hematological or solid neoplasms defined as high risk. The study will be prospective, based on the consecutive enrollment of eligible patients at each participating ins…
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
New hope for kids with heart failure: drug trial aims to improve heart function
Disease control Recruiting nowThis study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline to Week 16 of the Base Period. The primary hypothesis is that vericiguat is superior to placebo in reducing NT-proBNP at Week 16 of …
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Brain zap video game: could it sharpen your mind?
Symptom relief Recruiting nowThe goal of this clinical study is to investigate the effectiveness of non-invasive stimulation to enhance cognitive control abilities in cognitively healthy adults and older adults diagnosed with mild cognitive disorder (MCI). The main questions it aims to answer are: * whether…
Phase: NA • Sponsor: University of Texas at Austin • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Could a vaccine slow Parkinson's? early trial tests UB-312
Disease control CompletedThis is a Phase 1b study to determine the safety, tolerability, and immunogenicity of UB-312 in participants with multiple system atrophy (MSA), and in participants with Parkinson's disease (PD). UB-312 is a UBITh®-enhanced synthetic peptide-based vaccine and may provide an activ…
Phase: PHASE1 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC